Cargando…
Efficacy of ultra-short course chemotherapy for new smear positive drug susceptible pulmonary tuberculosis: study protocol of a multicenter randomized controlled clinical trial
BACKGROUND: Shortening the standard 6-month treatment for drug-susceptible pulmonary tuberculosis (DS-PTB) would be a major improvement for TB case management and disease control. METHODS: We are conducting a randomized, open-label, controlled, non-inferiority trial involving patients with smear-pos...
Autores principales: | Gao, Mengqiu, Gao, Jingtao, Du, Jian, Liu, Yuhong, Zhang, Yao, Ma, Liping, Mi, Fengling, Li, Liang, Tang, Shenjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474865/ https://www.ncbi.nlm.nih.gov/pubmed/28629333 http://dx.doi.org/10.1186/s12879-017-2505-7 |
Ejemplares similares
-
Clinical and genomic responses to ultra-short course chemotherapy in spinal tuberculosis
por: Niu, Ningkui, et al.
Publicado: (2017) -
Preoperative Ultra-Short-Course Chemotherapy Combined with Surgery for the Treatment of Chest Wall Tuberculosis
por: Zhang, Weidong, et al.
Publicado: (2020) -
Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis
por: Gao, Jingtao, et al.
Publicado: (2016) -
Preoperative sequential short-course radiation therapy and FOLFOX chemotherapy versus long-course chemoradiotherapy for locally advanced rectal cancer: a multicenter, randomized controlled trial (SOLAR trial)
por: Kang, Min Kyu, et al.
Publicado: (2023) -
Efficacy of integrating short-course chemotherapy with Chinese herbs to treat multi-drug resistant pulmonary tuberculosis in China: a study protocol
por: Zhang, Shun-Xian, et al.
Publicado: (2021)